Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer
Clinical trial NCT02229253 · COMPLETED
Trial details
- NCT number
- NCT02229253
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-10-04
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.